Coldstream Capital Management Inc Wave Life Sciences Ltd. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 369 shares of WVE stock, worth $2,291. This represents 0.0% of its overall portfolio holdings.
Number of Shares
369Holding current value
$2,291% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding WVE
# of Institutions
205Shares Held
125MCall Options Held
499KPut Options Held
180K-
Ra Capital Management, L.P. Boston, MA18.2MShares$113 Million3.05% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA12.5MShares$77.7 Million0.2% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$51.3 Million1.31% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$41.8 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.36MShares$39.5 Million0.56% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $539M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...